What is the Xiilab Co., Ltd. stock price forecast?

Xiilab Co., Ltd. is currently trading at ₩8,950. View real-time AI analysis on Alpha Lenz.

What is Xiilab Co., Ltd. insider trading activity?

View the latest insider trading data for Xiilab Co., Ltd. on Alpha Lenz.

What is Xiilab Co., Ltd.'s P/E ratio?

Xiilab Co., Ltd.'s P/E ratio is -12.1.

Xiilab Co., Ltd.

KRX · 189330

₩8,950

Ask about Xiilab Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Xiilab Co., Ltd. trades at a P/E of -12.1 (undervalued) with modest ROE of -42.5%. 3Y revenue CAGR of 16.3% highlights clear growth momentum.”

Ask for details →

Company Overview

Xiilab Co., Ltd. is a technology company specializing in big data solutions and artificial intelligence. The company develops platforms and software that leverage cutting-edge analytics to provide insights and data management services for various industries. Its offerings are designed to optimize business operations, enhance decision-making capabilities, and foster digital transformation in sectors such as finance, healthcare, and manufacturing. Xiilab's robust technology infrastructure supports cloud-based systems and internet of things (IoT) integration, making it a pivotal player in the burgeoning data-driven market. By focusing on innovation and advanced technology solutions, Xiilab Co., Ltd. plays a crucial role in helping companies harness the power of data analytics to drive efficiency and growth. Founded in South Korea, the company has built a reputation for reliability and technological leadership in the domestic market while expanding its reach globally.

CEO윤세혁, 채정환 (각자 대표이사)

Websitehttps://www.xiilab.com

SectorTechnology

IndustryInformation Technology Services

Employees62

Company Statistics

FY 2024

Profile

₩83,971,441,800Market Cap

₩9,093,357,970Revenue

9.38MShares Out

62Employees

Margins

14.41%Gross

-44.58%EBITDA

-58.12%Operating

-57.03%Pre-Tax

-57.04%Net

Valuation

-12.13P/E

6.56P/B

6.92EV/Sales

-14.99EV/EBITDA

-14.99P/FCF

Growth (CAGR)

16.32%Rev 3Yr

5.11%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-33.02%ROA

-42.49%ROE

-32.50%ROIC

Financial Health

₩3,232,153,000Cash & Cash Equivalents

₩563,849,580Net Debt

39.54%Debt/Equity

N/AInterest Cov